The gadolinium contrast class action lawsuits took a hit last week when the MDL Panel denied class certification which would have consolidated all of the federal court cases under one roof. But I’m convinced there will be an MDL class action in the gadolinium contrast cases in the next year. These deposition disease cases are still heating up in spite of this setback.
If you are a victim or a lawyer getting calls from clients, here are 7 things you need to know about the gadolinium contrast litigation.
What are GBCAs?